Axa
ALPN

Axa’s Alpine Immune Sciences Inc ALPN Stock Holding History

Axa’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-162,962
Closed -$5.3M – 1301
2016
Q3 		$5.3M Buy
162,962
+29,539
+22% +$719K 0.02% 558
2016
Q2 		$2.46M Buy
133,423
+34,913
+35% +$620K 0.01% 706
2016
Q1 		$1.64M Hold
98,510
– – 0.01% 790
2015
Q4 		$3.05M Buy
98,510
+13,573
+16% +$463K 0.01% 690
2015
Q3 		$4.41M Buy
84,937
+22,437
+36% +$1.47M 0.02% 605
2015
Q2 		$3.79M Buy
+62,500
New +$3.72M 0.02% 645

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's ALPN Position: Q4 2016 in Review

Axa sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2016, closing a stake of 162,962 shares — an estimated $5.3M sold.

Axa first reported a position in ALPN in Q2 2015 and held it in 6 quarters. The position peaked at $5.3M in Q3 2016. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • Axa reported no remaining Alpine Immune Sciences Inc position as of Q4 2016 after selling out during the quarter.
  • Axa sold 162,962 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $5.3M.
  • Axa first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 6 quarters.
  • Axa's Alpine Immune Sciences Inc position peaked at $5.3M in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on Axa's 13F filing for Q4 2016, filed 13 Feb 2017.